ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,861, issued on Sept. 16, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain).
"Anti C-MET antibodies" was invented by William James Jonathan Finlay (Glasgow, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibody molecules that bind specifically to C-MET and related nucleic acid molecules, vectors and host cells. Also provided herein are medical uses of such antibody molecules."
The patent was filed on April 21, 2023, under Application No. 18/304,598.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=...